FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Asplin

Research Profile

Anatomy

Chemicals & Drugs

Living Beings

Disorders

Concepts & Ideas

Procedures

Urinalysis

Co-author Network

Publications

TOP 3
Brian Becknell; Brad Bolon; Ashley R Carpenter; David S Hains; Susan E Ingraham; John R Asplin; Andrew L Schwaderer; Kirk M McHugh
Struvite urolithiasis and chronic urinary tract infection in a murine model of urinary diversion.
Kevin K Frick; Nancy S Krieger; John R Asplin; Christopher Culbertson; Murray J Favus; David A Bushinsky
Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats.
Onyeka W Okonkwo; Ignacio Granja; John R Asplin; Ruchika Batwara; David S Goldfarb
A pilot study of the effect of sodium thiosulfate on urinary lithogenicity and associated metabolic acid load in non-stone formers and stone formers with hypercalciuria.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Asplin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Brian Becknell; Brad Bolon; Ashley R Carpenter; David S Hains; Susan E Ingraham; John R Asplin; Andrew L Schwaderer; Kirk M McHugh
Struvite urolithiasis and chronic urinary tract infection in a murine model of urinary diversion.
Urology 2013;81(5):943-8.
2013: Kevin K Frick; Nancy S Krieger; John R Asplin; Christopher Culbertson; Murray J Favus; David A Bushinsky
Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats.
American journal of physiology. Renal physiology 2013;304(6):F718-26.
2013: Onyeka W Okonkwo; Ignacio Granja; John R Asplin; Ruchika Batwara; David S Goldfarb
A pilot study of the effect of sodium thiosulfate on urinary lithogenicity and associated metabolic acid load in non-stone formers and stone formers with hypercalciuria.
PloS one 2013;8(4):e60380.
2012: Kristin J Bergsland; Fredric L Coe; William R DeFoor; Michael J Erhard; John D Mahan; Andrew L Schwaderer; Mark D White; John R Asplin
Urine risk factors in children with calcium kidney stones and their siblings.
Kidney international 2012;81(11):1140-8.
2012: Nicola T Sumorok; Marshall L Stoller; John R Asplin; Brian H Eisner; David S Goldfarb
Effect of diet orange soda on urinary lithogenicity.
Urological research 2012;40(3):237-41.
2012: Guy M L Perry; Steven J Scheinman; John R Asplin
Weight, age and coefficients of variation in renal solute excretion.
Nephron. Physiology 2012;122(1-2):13-8.
2011: David A Bushinsky; Sara P Y Che; Christopher Culbertson; John R Asplin; Thomas Willett; Marc Grynpas
Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2011;26(8):1904-12.
2011: Kristin J Bergsland; Anna L Zisman; John R Asplin; Elaine M Worcester; Fredric L Coe
Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones.
American journal of physiology. Renal physiology 2011;300(2):F311-8.
2010: Fredric L Coe; John R Asplin
Medicine. Stopping the stones.
Science (New York, N.Y.) 2010;330(6002):325-6.
2009: John R Asplin; Susan E Donahue; Christina Lindeman; Anne Michalenka; Kelly Laplante Strutz; David A Bushinsky
Thiosulfate reduces calcium phosphate nephrolithiasis.
Journal of the American Society of Nephrology : JASN 2009;20(6):1246-53.
2008: John R Asplin
Evaluation of the kidney stone patient.
Seminars in nephrology 2008;28(2):99-110.
2008: John R Asplin
Nephrolithiasis: introduction.
Seminars in nephrology 2008;28(2):97-8.
2008: David A Bushinsky; A C Michalenka; K L Strutz; S Donahue; John R Asplin
Effect of bolus and divided feeding on urine ions and supersaturation in genetic hypercalciuric stone-forming rats.
Kidney international 2008;73(4):423-9.
2007: David S Goldfarb; Frank Modersitzki; John R Asplin
A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria.
Clinical journal of the American Society of Nephrology : CJASN 2007;2(4):745-9.
2007: John R Asplin; Fredric L Coe
Hyperoxaluria in kidney stone formers treated with modern bariatric surgery.
The Journal of urology 2007;177(2):565-9.
2006: John R Asplin; S Donahue; Jennifer M Kinder; Fredric L Coe
Urine calcium excretion predicts bone loss in idiopathic hypercalciuria.
Kidney international 2006;70(8):1463-7.
2006: Joshua Wolf; John R Asplin; David S Goldfarb
Chitosan does not reduce post-prandial urinary oxalate excretion.
Urological research 2006;34(4):227-30.
2006: David A Bushinsky; K Laplante; John R Asplin
Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats.
Kidney international 2006;69(9):1586-92.
2006: Zhirong Jiang; John R Asplin; Andrew P Evan; Vazhaikkurichi M Rajendran; Heino Velazquez; Timothy P Nottoli; Henry J Binder; Peter S Aronson
Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6.
Nature genetics 2006;38(4):474-8.
2006: David S Goldfarb; Fredric L Coe; John R Asplin
Urinary cystine excretion and capacity in patients with cystinuria.
Kidney international 2006;69(6):1041-7.
2005: Daniele J Dolin; John R Asplin; Leigh Flagel; Michael Grasso; David S Goldfarb
Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria.
Journal of endourology / Endourological Society 2005;19(3):429-32.
2005: David A Bushinsky; John R Asplin
Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
Journal of the American Society of Nephrology : JASN 2005;16(2):417-24.
2004: Rocky Pramanik; John R Asplin; Christina Lindeman; Murray J Favus; Shaochun Bai; Fredric L Coe
Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
Cellular immunology 2004;232(1-2):137-43.
2003: John R Asplin; Kimberly A Bauer; Jennifer M Kinder; Georg Müller; Brian J Coe; Joan H Parks; Fredric L Coe
Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis.
Kidney international 2003;63(2):662-9.
2002: John R Asplin
Hyperoxaluric calcium nephrolithiasis.
Endocrinology and metabolism clinics of North America 2002;31(4):927-49.
2002: Khalid A Raja; Scott J Schurman; Richard G D'mello; Douglas L Blowey; Paul Goodyer; Scott K Van Why; Robert Ploutz-Snyder; John R Asplin; Steven J Scheinman
Responsiveness of hypercalciuria to thiazide in Dent's disease.
Journal of the American Society of Nephrology : JASN 2002;13(12):2938-44.
2002: Kristin J Bergsland; Jennifer M Kinder; John R Asplin; Brian J Coe; Fredric L Coe
Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients.
The Journal of urology 2002;167(6):2372-6.
2002: John R Asplin; Joan H Parks; Yashushi Nakagawa; Fredric L Coe
Reduced crystallization inhibition by urine from women with nephrolithiasis.
Kidney international 2002;61(5):1821-9.
2002: Jennifer M Kinder; Cyndi D Clark; Brian J Coe; John R Asplin; Joan H Parks; Fredric L Coe
Urinary stone risk factors in the siblings of patients with calcium renal stones.
The Journal of urology 2002;167(5):1965-7.
2002: Joan H Parks; Evan Goldfisher; John R Asplin; Fredric L Coe
A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis.
The Journal of urology 2002;167(4):1607-12.
2002: David A Bushinsky; John R Asplin; Marc D Grynpas; Andrew P Evan; Walter R Parker; Kristen M Alexander; Fredric L Coe
Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
Kidney international 2002;61(3):975-87.
2001: Joan H Parks; John R Asplin; Fredric L Coe
Patient adherence to long-term medical treatment of kidney stones.
The Journal of urology 2001;166(6):2057-60.
2001: Fredric L Coe; H Wise; Joan H Parks; John R Asplin
Proportional reduction of urine supersaturation during nephrolithiasis treatment.
The Journal of urology 2001;166(4):1247-51.
2001: Fredric L Coe; C Clark; Joan H Parks; John R Asplin
Solid phase assay of urine cystine supersaturation in the presence of cystine binding drugs.
The Journal of urology 2001;166(2):688-93.
2001: Fredric L Coe; H Wise; Joan H Parks; P J Fleury; John R Asplin
Differences in urine volume and supersaturation in 2 physician networks.
The Journal of urology 2001;166(2):423-8.
2001: David S Goldfarb; John R Asplin
Effect of grapefruit juice on urinary lithogenicity.
The Journal of urology 2001;166(1):263-7.
2001: JR Hoyer; John R Asplin; L Otvos
Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals.
Kidney international 2001;60(1):77-82.
2001: David A Bushinsky; Marc Grynpas; John R Asplin
Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats.
Kidney international 2001;59(4):1415-23.
2000: Yashushi Nakagawa; John R Asplin; David S Goldfarb; Joan H Parks; Fredric L Coe
Clinical use of cystine supersaturation measurements.
The Journal of urology 2000;164(5):1481-5.
2000: David A Bushinsky; Walter R Parker; John R Asplin
Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
Kidney international 2000;57(2):550-60.
2000: Steven J Scheinman; JP Cox; SE Lloyd; SH Pearce; P V Salenger; Richard Hoopes; David A Bushinsky; Oliver Wrong; John R Asplin; C B Langman; Anthony G W Norden; Rajesh V Thakker
Isolated hypercalciuria with mutation in CLCN5: relevance to idiopathic hypercalciuria.
Kidney international 2000;57(1):232-9.
1999: John R Asplin; Joan H Parks; M S Chen; John C Lieske; F Gary Toback; S N Pillay; Yashushi Nakagawa; Fredric L Coe
Reduced crystallization inhibition by urine from men with nephrolithiasis.
Kidney international 1999;56(4):1505-16.
1999: James E Lingeman; R Kahnoski; Hal K Mardis; David S Goldfarb; Michael Grasso; S Lacy; Steven J Scheinman; John R Asplin; Joan H Parks; Fredric L Coe
Divergence between stone composition and urine supersaturation: clinical and laboratory implications.
The Journal of urology 1999;161(4):1077-81.
1999: David A Bushinsky; K J Neumann; John R Asplin; Nancy S Krieger
Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats.
Kidney international 1999;55(1):234-43.
1998: James E Lingeman; Hal K Mardis; R Kahnoski; David S Goldfarb; S Lacy; Michael Grasso; Steven J Scheinman; Joan H Parks; John R Asplin; Fredric L Coe
Medical reduction of stone risk in a network of treatment centers compared to a research clinic.
The Journal of urology 1998;160(5):1629-34.
1998: S N Pillay; John R Asplin; Fredric L Coe
Evidence that calgranulin is produced by kidney cells and is an inhibitor of calcium oxalate crystallization.
The American journal of physiology 1998;275(2 Pt 2):F255-61.
1998: John R Asplin; J Parks; James E Lingeman; R Kahnoski; Hal K Mardis; S Lacey; D Goldfarb; Michael Grasso; Fredric L Coe
Supersaturation and stone composition in a network of dispersed treatment sites.
The Journal of urology 1998;159(6):1821-5.
1998: John R Asplin; James E Lingeman; R Kahnoski; Hal K Mardis; Joan H Parks; Fredric L Coe
Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.
The Journal of urology 1998;159(3):664-8.
1998: John R Asplin; D Arsenault; Joan H Parks; Fredric L Coe; JR Hoyer
Contribution of human uropontin to inhibition of calcium oxalate crystallization.
Kidney international 1998;53(1):194-9.
1997: John R Asplin; Joan H Parks; Fredric L Coe
Dependence of upper limit of metastability on supersaturation in nephrolithiasis.
Kidney international 1997;52(6):1602-8.
1997: John R Asplin; David A Bushinsky; W Singharetnam; DR Riordon; Joan H Parks; Fredric L Coe
Relationship between supersaturation and crystal inhibition in hypercalciuric rats.
Kidney international 1997;51(3):640-5.
1996: John R Asplin
Uric acid stones.
Seminars in nephrology 1996;16(5):412-24.
1996: John R Asplin; N S Mandel; Fredric L Coe
Evidence of calcium phosphate supersaturation in the loop of Henle.
The American journal of physiology 1996;270(4 Pt 2):F604-13.
1996: J L Porile; John R Asplin; Joan H Parks; Yashushi Nakagawa; Fredric L Coe
Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis.
Journal of the American Society of Nephrology : JASN 1996;7(4):602-7.
1994: Fredric L Coe; Yashushi Nakagawa; John R Asplin; Joan H Parks
Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
Mineral and electrolyte metabolism 1994;20(6):378-84.
1992: Fredric L Coe; Joan H Parks; John R Asplin
The pathogenesis and treatment of kidney stones.
The New England journal of medicine 1992;327(16):1141-52.
1991: John R Asplin; Sergio Deganello; Yashushi Nakagawa; Fredric L Coe
Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals.
The American journal of physiology 1991;261(5 Pt 2):F824-30.